The development of Rigvir is described, starting with preclinical screening and including clinical experience.
Rigvir is the first-in-class of a new mode of action oncological treatment.
This is currently the most up-to-date review of the oncolytic virus Rigvir.Dr Peteris Alberts, PhD
Eur J Pharmacol 2018 Oct 1;837:117-126. Epub 2018 Sep 1.
International Virotherapy Center, Teātra iela 9-9, Riga LV-1050, Latvia.
Download full-text PDF